Abstract:Inflammation and oxidative stress are common and co-substantial pathological processes accompanying, promoting, and even initiating numerous cancers. The canonical WNT/β-catenin pathway and peroxisome proliferator-activated receptor gamma (PPARγ) generally work in opposition. If one of them is upregulated, the other one is downregulated and <i>vice versa</i>. WNT/β-catenin signaling is upregulated in inflammatory processes and oxidative stress and in many cancers, although there are some exceptions for cancers. The opposite is observed with PPARγ, which is generally downregulated during inflammation and oxidative stress and in many cancers. This helps to explain in part the opposite and unidirectional profile of the canonical WNT/β-catenin signaling and PPARγ in these three frequent and morbid processes that potentiate each other and create a vicious circle. Many intracellular pathways commonly involved downstream will help maintain and amplify inflammation, oxidative stress, and cancer. Thus, many WNT/β-catenin target genes such as c-Myc, cyclin D1, and HIF-1α are involved in the development of cancers. Nuclear factor-kappaB (NFκB) can activate many inflammatory factors such as TNF-α, TGF-β, interleukin-6 (IL-6), IL-8, MMP, vascular endothelial growth factor, COX2, Bcl2, and inducible nitric oxide synthase. These factors are often associated with cancerous processes and may even promote them. Reactive oxygen species (ROS), generated by cellular alterations, stimulate the production of inflammatory factors such as NFκB, signal transducer and activator transcription, activator protein-1, and HIF-α. NFκB inhibits glycogen synthase kinase-3β (GSK-3β) and therefore activates the canonical WNT pathway. ROS activates the phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) signaling in many cancers. PI3K/Akt also inhibits GSK-3β. Many gene mutations of the canonical WNT/β-catenin pathway giving rise to cancers have been reported (CTNNB1, AXIN, APC). Conversely, a significant reduction in the expression of PPARγ has been observed in many cancers. Moreover, PPARγ agonists promote cell cycle arrest, cell differentiation, and apoptosis and reduce inflammation, angiogenesis, oxidative stress, cell proliferation, invasion, and cell migration. All these complex and opposing interactions between the canonical WNT/β-catenin pathway and PPARγ appear to be fairly common in inflammation, oxidative stress, and cancers.

Inflammation-Associated Carcinogenesis Involves Interaction Between the iNOS/NO and Wnt/β-catenin Signaling Pathways

From Inflammation to Cancer: the Molecular Basis

Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription

Inflammation-Induced Tumorigenesis In The Colon Is Regulated By Caspase-1 And Nlrc4

Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications

Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer

Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation

Inflammation-Induced Tumorigenesis: Diminished Noncanonical NF-κB Signaling is Associated with Pathogenesis of Colitis-associated Colorectal Cancer

Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice

The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity

Significance of iNOS and NF-κB expression in Helicobacter pylori infection and its associated diseases and relation between iNOS and NF-κB

WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment

NF-κB, inflammation, immunity and cancer: coming of age

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

Abstract B86: the NF-κB P65 and P50 Homodimer Cooperate with Pstat1 to Synergistically Activate Inos Transcription

NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

The NF-κB P65 and P50 Homodimer Cooperate with Pstat1 to Synergistically Activate Inos Transcription in Cancer Cells and Myeloid Cells (INM1P.440)

Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.